BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anderson JL, Hedin CR, Benjamin JL, Koutsoumpas A, Ng SC, Hart AL, Forbes A, Stagg AJ, Lindsay JO, Whelan K. Dietary intake of inulin-type fructans in active and inactive Crohn’s disease and healthy controls: a case–control study. ECCOJC 2015;9:1024-31. [DOI: 10.1093/ecco-jcc/jjv136] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Rej A, Sanders DS, Buckle RL, Trott N, Aziz I, Shaw CC. What is the optimal FODMAP threshold in IBS? J Gastroenterol Hepatol 2021;36:1723-5. [PMID: 33624857 DOI: 10.1111/jgh.15470] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Bodini G, Zanella C, Crespi M, Lo Pumo S, Demarzo MG, Savarino E, Savarino V, Giannini EG. A randomized, 6-wk trial of a low FODMAP diet in patients with inflammatory bowel disease. Nutrition 2019;67-68:110542. [PMID: 31470260 DOI: 10.1016/j.nut.2019.06.023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
3 Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol. 2016;7:e164. [PMID: 27077959 DOI: 10.1038/ctg.2016.22] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 10.3] [Reference Citation Analysis]
4 Serrano-moreno C, Brox-torrecilla N, Arhip L, Romero I, Morales Á, Carrascal ML, Cuerda C, Motilla M, Camblor M, Velasco C, Bretón I. Diets for inflammatory bowel disease: What do we know so far? Eur J Clin Nutr. [DOI: 10.1038/s41430-021-01051-9] [Reference Citation Analysis]
5 Wilson B, Whelan K. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders. J Gastroenterol Hepatol 2017;32 Suppl 1:64-8. [PMID: 28244671 DOI: 10.1111/jgh.13700] [Cited by in Crossref: 119] [Cited by in F6Publishing: 95] [Article Influence: 23.8] [Reference Citation Analysis]
6 Cox SR, Prince AC, Myers CE, Irving PM, Lindsay JO, Lomer MC, Whelan K. Fermentable Carbohydrates [FODMAPs] Exacerbate Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: A Randomised, Double-blind, Placebo-controlled, Cross-over, Re-challenge Trial. J Crohns Colitis. 2017;11:1420-1429. [PMID: 28525543 DOI: 10.1093/ecco-jcc/jjx073] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 13.8] [Reference Citation Analysis]
7 Day AS, Davis R, Costello SP, Yao CK, Andrews JM, Bryant RV. The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. J Acad Nutr Diet 2021;121:688-708.e3. [PMID: 33485803 DOI: 10.1016/j.jand.2020.12.001] [Reference Citation Analysis]
8 Wong C, Harris PJ, Ferguson LR. Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease. Int J Mol Sci 2016;17:E919. [PMID: 27314323 DOI: 10.3390/ijms17060919] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
9 Lockyer S, Stanner S. Prebiotics – an added benefit of some fibre types. Nutr Bull 2019;44:74-91. [DOI: 10.1111/nbu.12366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
10 Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Stagg AJ, Lindsay JO, Whelan K. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease. Clin Nutr 2021;40:5009-19. [PMID: 34364241 DOI: 10.1016/j.clnu.2021.05.033] [Reference Citation Analysis]
11 Fortea M, Albert-Bayo M, Abril-Gil M, Ganda Mall JP, Serra-Ruiz X, Henao-Paez A, Expósito E, González-Castro AM, Guagnozzi D, Lobo B, Alonso-Cotoner C, Santos J. Present and Future Therapeutic Approaches to Barrier Dysfunction. Front Nutr 2021;8:718093. [PMID: 34778332 DOI: 10.3389/fnut.2021.718093] [Reference Citation Analysis]
12 Lockyer S, Spiro A. The role of bread in the UK diet: An update. Nutr Bull 2020;45:133-64. [DOI: 10.1111/nbu.12435] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
13 Killian LA, Muir JG, Barrett JS, Burd NA, Lee SY. High Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Consumption Among Endurance Athletes and Relationship to Gastrointestinal Symptoms. Front Nutr 2021;8:637160. [PMID: 33959628 DOI: 10.3389/fnut.2021.637160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Davis R, Day A, Barrett J, Vanlint A, Andrews JM, Costello SP, Bryant RV. Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross‐sectional study. J Hum Nutr Diet 2021;34:420-8. [DOI: 10.1111/jhn.12812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Gibson PR. Use of the low-FODMAP diet in inflammatory bowel disease. J Gastroenterol Hepatol. 2017;32 Suppl 1:40-42. [PMID: 28244679 DOI: 10.1111/jgh.13695] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 9.4] [Reference Citation Analysis]
16 Prince AC, Myers CE, Joyce T, Irving P, Lomer M, Whelan K. Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22:1129-1136. [PMID: 26914438 DOI: 10.1097/mib.0000000000000708] [Cited by in Crossref: 92] [Cited by in F6Publishing: 37] [Article Influence: 18.4] [Reference Citation Analysis]
17 Cox SR, Clarke H, O'Keeffe M, Dubois P, Irving PM, Lindsay JO, Whelan K. Nutrient, fibre and FODMAP intakes and food-related quality of life in patients with inflammatory bowel disease and their relationship with gastrointestinal symptoms of differing aetiologies. J Crohns Colitis 2021:jjab116. [PMID: 34216206 DOI: 10.1093/ecco-jcc/jjab116] [Reference Citation Analysis]
18 Liljebo T, Störsrud S, Andreasson A. Presence of Fermentable Oligo-, Di-, Monosaccharides, and Polyols (FODMAPs) in commonly eaten foods: extension of a database to indicate dietary FODMAP content and calculation of intake in the general population from food diary data. BMC Nutr 2020;6:47. [PMID: 32963797 DOI: 10.1186/s40795-020-00374-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Roncoroni L, Gori R, Elli L, Tontini GE, Doneda L, Norsa L, Cuomo M, Lombardo V, Scricciolo A, Caprioli F, Costantino A, Scaramella L, Vecchi M. Nutrition in Patients with Inflammatory Bowel Diseases: A Narrative Review. Nutrients 2022;14:751. [DOI: 10.3390/nu14040751] [Reference Citation Analysis]
20 Shen S, Wong CH. Bugging inflammation: role of the gut microbiota. Clin Transl Immunology 2016;5:e72. [PMID: 27195115 DOI: 10.1038/cti.2016.12] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
21 Spiller R, Major G. IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13:613-621. [PMID: 27667579 DOI: 10.1038/nrgastro.2016.141] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 14.0] [Reference Citation Analysis]